Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDO2 | P48775 | 13/20 | 0.40 |
| ▸ | IDO1 | P14902 | 10/20 | 0.40 |
| ▸ | ELANE | P08246 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.36 |
| ▸ | BRAF | P15056 | 1/20 | 0.36 |
| ▸ | EIF2AK3 | Q9NZJ5 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22373914 | 0.86 | ELANE (0.38) | TDO2IDO1ELANEALDH1A1MAPT | |
| SCHEMBL17115248 | 0.81 | TDO2 (0.41) | TDO2IDO1ALDH1A1SMN1; SMN2ROCK2 | |
| SCHEMBL17490043 | 0.79 | LMNA (0.50) | TDO2IDO1 | |
| SCHEMBL27401128 | 0.79 | TDO2 (0.40) | TDO2IDO1ROCK2 | |
| SCHEMBL20308260 | 0.79 | TDO2 (0.43) | TDO2IDO1ROCK2 | |
| SCHEMBL23947329 | 0.79 | TDO2 (0.40) | TDO2IDO1 | |
| SCHEMBL19051921 | 0.79 | IDO1 (0.42) | TDO2IDO1ALDH1A1MAPTKMT2A | |
| SCHEMBL24056383 | 0.79 | TDO2 (0.46) | TDO2IDO1ROCK2BRAFEIF2AK3 | |
| SCHEMBL20308264 | 0.79 | TDO2 (0.40) | TDO2IDO1ROCK2 | |
| SCHEMBL21237825 | 0.78 | IDO1 (0.43) | TDO2IDO1ELANEROCK2BRAF |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2023-11-30 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-11758807-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION | 2023-09-12 | — | — | US | disclosed |
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | WUHAN TIANMA MICRO-ELECTRONICS CO., LTD. (CN) | 2023-06-01 | — | — | US | disclosed |
| US-20210367162-A1 | HETEROCYCLIC COMPOUND AND LIGHT-EMITTING DEVICE INCLUDING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-11-25 | — | — | US | disclosed |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | UNIVERSAL DISPLAY CORPORATION | 2020-08-27 | — | — | US | disclosed |
| WO-2009147476-A1 | NOVEL PDE INHIBITORS, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND PROCESSES FOR THEIR PREPARATION | MATRIX LABORATORIES LTD. (IN) | 2009-12-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230389413-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | TDO2 4168/4885IDO1 3021/4885ELANE 1569/4885 |
| US-20200274081-A1 | Organic Electroluminescent Materials and Devices | GLRA3, ESRRG, GLRA1 | TDO2 4168/4885IDO1 3021/4885ELANE 1569/4885 |
| US-20230172057-A1 | HETEROCYCLIC COMPOUND CONTAINING HETEROATOM SUBSTITUTED FLUORENE AND OPTOELECTRONIC DEVICE | CHRM1, CHRM2, CHRM4 | TDO2 122/4885IDO1 623/4885ELANE 2540/4885 |
| US-11758807-B2 | Organic electroluminescent materials and devices | GLRA3, ESRRG, GLRA1 | TDO2 4168/4885IDO1 3021/4885ELANE 1569/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.